Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Aug 14 2018

Full Issue

Google's DeepMind AI Not Only Identifies Eye Diseases But Goes Step Further And Explains Its Conclusions

Being able to explain how the artificial intelligence technology reached its diagnoses for dozens of eye ailments is a breakthrough and a crucial step toward outperforming the work of human doctors, according to the study in Nature Medicine.

Stat: Google DeepMind AI System Diagnoses Eye Diseases And Shows Its Work 

In eye care, artificial intelligence systems have shown they can match the accuracy of doctors in diagnosing specific diseases. But a new system designed by Google DeepMind and British doctors goes a crucial step further: It can show users how it reached its conclusions. A study published Monday in Nature Medicine reports that the DeepMind system can identify dozens of diseases and point out the portions of optical coherence tomography scans that it relies upon to make its diagnoses. That’s a crucial factor in validating the safety and efficacy of AI technologies being developed for use in diagnosing or recommending treatments for a broad range of diseases, from cancer to neurological and vision problems. (Ross, 8/13)

Bloomberg: Google’s DeepMind To Create Product To Spot Eye Disease 

DeepMind and its partners in the research, London’s Moorfields Eye Hospital and the University College London Institute of Ophthalmology, said they plan prospective clinical trials of the technology in 2019. If those trials are successful, DeepMind said it would seek to create a regulator-approved product that Moorfields could roll out across the U.K. It said the product would be free for an initial five-year period. The software would be the first time a DeepMind AI algorithm using machine learning has ended up in a healthcare product. (Kahn, 8/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF